IFP Advisors Inc bought a new stake in Ultralife Co. (NASDAQ:ULBI – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,400 shares of the technology company’s stock, valued at approximately $85,000. IFP Advisors Inc owned 0.07% of Ultralife as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently modified their holdings of the business. Janney Montgomery Scott LLC boosted its position in shares of Ultralife by 0.9% in the fourth quarter. Janney Montgomery Scott LLC now owns 447,000 shares of the technology company’s stock valued at $3,330,000 after acquiring an additional 3,850 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Ultralife by 250.8% in the third quarter. JPMorgan Chase & Co. now owns 47,458 shares of the technology company’s stock valued at $429,000 after acquiring an additional 33,929 shares during the period. Barclays PLC boosted its position in shares of Ultralife by 21.3% in the third quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock valued at $121,000 after acquiring an additional 2,355 shares during the period. Geode Capital Management LLC boosted its position in shares of Ultralife by 1.2% in the third quarter. Geode Capital Management LLC now owns 232,681 shares of the technology company’s stock valued at $2,104,000 after acquiring an additional 2,835 shares during the period. Finally, Jane Street Group LLC bought a new stake in shares of Ultralife in the third quarter valued at about $166,000. Institutional investors own 30.68% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Benchmark reaffirmed a “buy” rating and issued a $14.00 price target on shares of Ultralife in a research note on Friday, November 15th.
Ultralife Stock Up 2.6 %
ULBI stock opened at $6.02 on Thursday. The company has a market cap of $100.09 million, a PE ratio of 10.95 and a beta of 0.96. The business has a 50-day simple moving average of $7.35 and a 200 day simple moving average of $8.28. Ultralife Co. has a 52 week low of $5.79 and a 52 week high of $13.39. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04.
About Ultralife
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
See Also
- Five stocks we like better than Ultralife
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Upcoming IPO Stock Lockup Period, Explained
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Is Advanced Micro Devices Stock Slide Over?
Want to see what other hedge funds are holding ULBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ultralife Co. (NASDAQ:ULBI – Free Report).
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.